Data from Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer - Elena Shagisultanova; William Gradishar; Ursa Brown-Glaberman; Pavani Chalasani; Andrew J. Brenner; Alison Stopeck; Hannah Parris; Dexiang Gao; Tessa McSpadden; Jose Mayordomo; Jennifer R. Diamond; Peter Kabos; et al. (2023)